FDA Reissues J&J Vaccine Authorization with Restrictions
The Food and Drug Administration announced that it would reissue the Emergency Use Authorization for the emergency use of the Janssen COVID-19 vaccine with certain revisions to its authorized use.  Specifically, the authorized use of the vaccine will be limited to individuals 18 years of age or older who cannot receive other FDA-authorized COVID-19 vaccines because they are either not accessible or not clinically appropriate, or who would not receive a COVID-19 vaccine otherwise.

Back to Top of Page

  • * * *